Robotic versus laparoscopic colectomy for transverse colon cancer: a systematic review and meta-analysis.

Candida Bonelli, Andrea Morini, Magda Zanelli, Lucia Mangone, Maurizio Zizzo, Francesca Sanguedolce, Andrea Palicelli, Massimiliano Fabozzi

Journal: International journal of colorectal disease 2025;40(1):79

PMID: 40172685

Abstract

PURPOSE

Transverse colon cancer, which accounts for approximately 10% of all colon cancers, has a significant gap in the available scientific literature regarding the optimal minimally invasive surgical approach. This meta-analysis aims to compare the robotic and laparoscopic approaches for the surgical management of transverse colon cancer.

METHODS

Our systematic review made use of Preferred Reporting Items for Systematic Reviews and Meta-analysis (PRISMA) guidelines, in addition to Cochrane Handbook for Systematic Reviews of Interventions. Articles of interest turned out from a search with PubMed/MEDLINE, Cochrane Library (Cochrane Database of Systematic Reviews, Cochrane Central Register of Controlled Trials-CENTRAL), Web of Science (Science and Social Science Citation Index), and Embase databases. A comprehensive literature search was conducted for comparative population studies concerning patients who underwent robotic or laparoscopic colectomy for transverse colon cancer). The risk of bias was assessed by the Cochrane Risk-of-Bias tool for randomized trials (Version 2) (RoB 2) and the Risk Of Bias In Non-randomized Studies - of Interventions (Version 2) ROBINS-I. We evaluated two groups of outcomes: intraoperative and postoperative. RevMan (Computer program) Version 5.4.1 was used to perform the meta-analysis. The heterogeneity of the included studies in the meta-analysis was assessed by using the I statist.

RESULTS

The 4 included comparative studies (373 patients: 116 robotic colectomy versus 257 laparoscopic colectomy) had a time frame of approximately 26 years (2005-2021) and an observational nature. Meta-analysis showed a longer operative time (MD: 62.47, 95% CI: 18.17, 106.76, I = 92%, P = 0.006) and a shorter hospital stay (MD:-1.11, 95% CI: -2.05, -0.18, I = 63%, P = 0.002) for the robotic group. No differences in terms of conversion to laparotomy, estimated blood loss, time to flatus, time to solid diet, overall postoperative complications rate, minor (Clavien-Dindo or CD I-II) and major (Clavien-Dindo or CD ≥ III) postoperative complications rate, anastomotic leakage, surgical site infections, bleeding, lymph nodes harvested, were shown between robotic and laparoscopic groups.

CONCLUSIONS

Our meta-analysis revealed that the robotic approach to transverse colon cancer appears to be a safe and feasible option, with results comparable to those of laparoscopic surgery, with longer operating times but a shorter hospital stay. Further high-quality methodological studies are needed to evaluate and compare the short- and long-term outcomes, healthcare costs, and the learning curve between the robotic and laparoscopic surgical approaches.

© 2025. The Author(s).

Address: Surgical Oncology Unit, Azienda USL - IRCCS Di Reggio Emilia, Viale Risorgimento 80, 42123, Reggio Emilia, Italy. [email protected].; Surgical Oncology Unit, Azienda USL - IRCCS Di Reggio Emilia, Viale Risorgimento 80, 42123, Reggio Emilia, Italy. [email protected].; Pathology Unit, Azienda USL-IRCCS Di Reggio Emilia, Reggio Emilia, Italy.; Pathology Unit, Policlinico Riuniti, University of Foggia, Foggia, Italy.; Oncology Department, Azienda USL-IRCCS Di Reggio Emilia, Reggio Emilia, Italy.; Epidemiology Unit, Azienda USL-IRCCS Di Reggio Emilia, Reggio Emilia, Italy.; Surgical Oncology Unit, Azienda USL - IRCCS Di Reggio Emilia, Viale Risorgimento 80, 42123, Reggio Emilia, Italy.

Link outs

Subscription / membership required

Bant logo

© Copyright 2026, Nutrition Evidence

NED wishes to thank the following organisations for their support:

We use cookies to improve your experience and analyze site traffic with Google Analytics. By continuing to use our site, you agree to our use of cookies. Learn more.